Speaker illustration

Professor Aaron Sverdlov

University of Newcastle, Newcastle (Australia)

Member of:

European Society of Cardiology
Heart Failure Association

Aaron Sverdlov is Professor and Director of Heart Failure at the University of Newcastle, Australia. Aaron is a clinician-scientist with track record in basic through to clinical research. Ha has co-established and co-leads the first in Australia bench-to-bedside dedicated Cardio-Oncology Clinical and Research program. The program incorporates basic mechanistic studies, drug discovery studies, translational human research, clinical research, and clinical service delivery and has just become the first program in Australia to receive highest tier accreditation as Centre of Excellence in Cardio-Oncology from the International Cardio-Oncology Society. Aaron has received more than $18 million in research funding and co-authored >100 papers.

Galectin 3 predicts improvement in LV volumes after Cardiac Resynchronisation Therapy


Topic: Cardiac resynchronisation therapy

Session: Devices / CRT / ICD


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb